Dieckol as a novel anti-proliferative and anti-angiogenic agent and computational anti-angiogenic activity evaluation

被引:16
|
作者
Li, Yong-Xin [1 ]
Li, Yong [2 ]
Je, Jae-Young [3 ]
Kim, Se-Kwon [1 ,3 ]
机构
[1] Pukyong Natl Univ, Marine Bioproc Res Ctr, Pusan 608737, South Korea
[2] Changchun Univ Chinese Med, Sch Pharmaceut Sci, Chanchun City, Jilin Province, Peoples R China
[3] Pukyong Natl Univ, Specialized Grad Sch Sci & Technol Convergence, Dept Marine Bio Convergence Sci, Pusan 608737, South Korea
关键词
Dieckol; Phlorotannins; Anti-angiogenic agent; MAPK pathway; Molecular docking server; ENDOTHELIAL GROWTH-FACTOR; EXPRESSION; ANTIOXIDANT; INVASION; DOCKING; MMP-9;
D O I
10.1016/j.etap.2014.11.027
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
In the current study it was found that dieckol isolated from edible brown algae, Ecklonia cava (EC), as potent anti-proliferative and anti-angiogenic agent. Vascular endothelial growth factor (VEGF) induced EA.hy926 cell proliferation was suppressed by dieckol treatment. Further, it showed a significant inhibition of cell migration via inhibiting the protein and gene expression levels of matrix metalloproteinases, MMP-2 and -9. The signaling cascade underlying these responses was found as the dieckol induced inhibition of mitogen-activated protein kinase (MAPK) signaling pathway molecules, ERK and p38. Docking calculations were carried out on AP-N, VEGFR-1, MMP-2, MMP-9, Akt and Erk2 proteins model. Collectively, these results demonstrate the effective anti-proliferative and anti-migratory activity of dieckol on VEGF induced EA.hy926 through MAPK molecular signaling pathways which could be effectively correlated to its potential as an anti-angiogenic candidate. Therefore, this study reveals the potential of dieckol to be used in the design of anti-angiogenic agents. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:259 / 270
页数:12
相关论文
共 50 条
  • [21] Fenretinide as an anti-angiogenic agent in neuroblastoma
    Ribatti, D
    Raffaghello, L
    Marimpietri, D
    Cosimo, E
    Montaldo, PG
    Nico, B
    Vacca, A
    Ponzoni, M
    [J]. CANCER LETTERS, 2003, 197 (1-2) : 181 - 184
  • [22] Novel pyrazole derivatives: Synthesis and evaluation of anti-angiogenic activity
    Christodoulou, Michael S.
    Liekens, Sandra
    Kasiotis, Konstantinos M.
    Haroutounian, Serkos A.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (12) : 4338 - 4350
  • [23] Synthesis and biological evaluation of novel indolocarbazoles with anti-angiogenic activity
    Acero, Nuria
    Brana, Miguel F.
    Anorbe, Loreto
    Dominguez, Gema
    Munoz-Mingarro, Dolores
    Mitjans, Francesc
    Piulats, Jaume
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 48 : 108 - 113
  • [24] Anti-angiogenic immunotherapy
    Schoenfeld, Jonathan D.
    Dranoff, Glenn
    [J]. HUMAN VACCINES, 2011, 7 (09): : 976 - 981
  • [25] Anti-angiogenic activity of a novel synthetic agent, 9α-fluoromedroxyprogesterone acetate
    Yamaji, T
    Tsuboi, H
    Murata, N
    Uchida, M
    Kohno, T
    Sugino, E
    Hibino, S
    Shimamura, M
    Oikawa, T
    [J]. CANCER LETTERS, 1999, 145 (1-2) : 107 - 114
  • [26] Evading anti-angiogenic therapy: resistance to anti-angiogenic therapy in solid tumors
    Dey, Nandini
    De, Pradip
    Brian, Leyland-Jones
    [J]. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2015, 7 (10): : 1675 - 1698
  • [27] ANTI-ANGIOGENIC ACTIVITY OF TRITERPENE ACIDS
    SHON, KH
    LEE, HY
    CHUNG, HY
    YOUNG, HS
    YI, SY
    KIM, KW
    [J]. CANCER LETTERS, 1995, 94 (02) : 213 - 218
  • [28] Anti-angiogenic and anti-proliferative activity of ziziphus leaf extract as a novel potential therapeutic agent for reducing hepatic injury in experimental hamster schistosomiasis
    Alghamdi, Thamer
    Salem, Doaa A.
    El-Refaei, Mohamed F.
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2023, 17 (06):
  • [29] Anti-angiogenic activity of contortrostatin.
    Golubkov, V
    Markland, FS
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (10) : 1207S - 1207S
  • [30] Implants composed of digoxin and poly(ε-caprolactone): development, characterization, anti-proliferative and anti-angiogenic activities
    Rodrigues, F. F.
    Braz, W. R.
    Perasoli, F. B.
    Ferreira, L. G. R.
    Barbosa, L. A. De O.
    Da Silva, G. R.
    [J]. PHARMAZIE, 2017, 72 (07): : 383 - 388